NU Skin Enterprises (NUS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 173,553 | 133,441 | 89,351 | 43,002 | 121,887 |
| Depreciation Amortization | 76,650 | 57,964 | 38,659 | 19,607 | 83,003 |
| Income taxes - deferred | 1,965 | 1,945 | 5,854 | 1,668 | -14,929 |
| Accounts receivable | 2,746 | -3,981 | -8,220 | -4,145 | -10,453 |
| Accounts payable and accrued liabilities | -7,184 | -6,609 | 1,606 | 5,157 | -9,164 |
| Other Working Capital | -132,435 | -112,610 | -91,881 | -89,337 | -71,884 |
| Other Operating Activity | 62,636 | 57,878 | 39,108 | 15,862 | 104,278 |
| Operating Cash Flow | $177,931 | $128,028 | $74,477 | $-8,186 | $202,738 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -66,067 | -52,784 | -29,214 | -13,765 | -70,371 |
| Net Acquisitions | -8,073 | -8,073 | -8,073 | -7,500 | -38,506 |
| Purchase Of Investment | -8,432 | -8,432 | -4,774 | -4,321 | -11,420 |
| Sale Of Investment | 11,160 | 11,160 | 7,615 | 7,444 | 11,536 |
| Investing Cash Flow | $-71,412 | $-58,129 | $-34,446 | $-18,142 | $-108,761 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 145,000 | 145,000 | 130,000 | 105,000 | 582,398 |
| Debt Repayment | -214,455 | -209,455 | -152,455 | -134,455 | -552,500 |
| Common Stock Issued | -2,325 | -2,326 | -2,308 | -2,156 | 10,777 |
| Common Stock Repurchased | -825 | -825 | -825 | -825 | -69,565 |
| Dividend Paid | -82,189 | -61,636 | -41,084 | -20,531 | -80,581 |
| Other Financing Activity | 0 | 0 | 0 | 0 | -7,243 |
| Financing Cash Flow | $-154,794 | $-129,242 | $-66,672 | $-52,967 | $-116,714 |
| Exchange Rate Effect | -3,006 | -7,534 | 362 | 2,672 | -16,751 |
| Beginning Cash Position | 386,911 | 386,911 | 386,911 | 386,911 | 426,399 |
| End Cash Position | 335,630 | 320,034 | 360,632 | 310,288 | 386,911 |
| Net Cash Flow | $-51,281 | $-66,877 | $-26,279 | $-76,623 | $-39,488 |
| Free Cash Flow | |||||
| Operating Cash Flow | 177,931 | 128,028 | 74,477 | -8,186 | 202,738 |
| Capital Expenditure | -66,067 | -52,784 | -29,214 | -13,765 | -70,371 |
| Free Cash Flow | 111,864 | 75,244 | 45,263 | -21,951 | 132,367 |